TENCIBAVI

Serial Number 90426716
Registration 6861970
700

Registration Progress

Application Filed
Dec 29, 2020
Under Examination
Dec 14, 2021
Approved for Publication
Oct 19, 2021
Published for Opposition
Oct 19, 2021
Registered
Oct 4, 2022

Trademark Image

TENCIBAVI

Basic Information

Serial Number
90426716
Registration Number
6861970
Filing Date
December 29, 2020
Registration Date
October 4, 2022
Published for Opposition
October 19, 2021
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
Oct 4, 2022
Registration
Registered
Classes
005

Rights Holder

Takeda Pharmaceuticals International AG

99
Address
Thurgauerstrasse 130
Glattpark-Opfikon 8152
CH

Ownership History

Takeda Pharmaceuticals International AG

Original Applicant
99
Glattpark-Opfikon CH

Takeda Pharmaceuticals International AG

Owner at Publication
99
Glattpark-Opfikon CH

Takeda Pharmaceuticals International AG

Original Registrant
99
Glattpark-Opfikon CH

Legal Representation

Attorney
Karl M. Zielaznicki, Esq.

USPTO Deadlines

Next Deadline
1171 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-10-04)
Due Date
October 04, 2028
Grace Period Ends
April 04, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

31 events
Date Code Type Description Documents
Oct 4, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Oct 4, 2022 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Aug 31, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Aug 31, 2022 DP1B I 1(B) BASIS DELETED; PROCEED TO REGISTRATION Loading...
Aug 29, 2022 D1BR I TEAS DELETE 1(B) BASIS RECEIVED Loading...
Aug 29, 2022 IUCN S NOTICE OF ALLOWANCE CANCELLED Loading...
Apr 1, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 30, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 30, 2022 EXT1 S SOU EXTENSION 1 FILED Loading...
Mar 30, 2022 EX1G S SOU EXTENSION 1 GRANTED Loading...
Dec 14, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 19, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 19, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 29, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 16, 2021 FIXD O ELECTRONIC RECORD REVIEW COMPLETE Loading...
Aug 20, 2021 ERRR O ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED Loading...
Aug 13, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 11, 2021 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Aug 10, 2021 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Aug 10, 2021 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Aug 10, 2021 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jul 21, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 21, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 20, 2021 ALIE A ASSIGNED TO LIE Loading...
Jun 30, 2021 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Jun 28, 2021 CNSL R SUSPENSION LETTER WRITTEN Loading...
Jun 28, 2021 GNSL F LETTER OF SUSPENSION E-MAILED Loading...
Jun 28, 2021 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Jun 26, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 22, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 1, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of infectious diseases
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Translation
The wording "Tencibavi" has no meaning in a foreign language.

Classification

International Classes
005